Stay updated on Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. The change appears to modify only version metadata and does not alter study records or visible content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.1%

- Check43 days agoChange DetectedThe history now shows Revision: v3.4.3. The previous Revision: v3.4.2 entry was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision history shows a new Revision: v3.4.2 added and the operating-status funding notice removed.SummaryDifference0.5%

- Check79 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and the NIH Clinical Center's operating status. Updated the page version to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check86 days agoChange DetectedGlossary toggle added; additions are highlighted in green and deletions in red, and the page now displays Revision: v3.4.0.SummaryDifference0.7%

Stay in the know with updates to Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.